Affidea completes investment in b-rayZ

Niederer Kraft Frey AG | View firm profile

11 July 2025

Niederer Kraft Frey advised Affidea on its investment in b-rayZ as part of a new financing round.

b-rayZ is at the forefront of breast imaging technology, offering state-of-the-art AI and Swiss medical expertise to improve early breast cancer detection and patient outcomes.

The Affidea Group is the pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, which operates in 391 medical centres across 15 countries.

The NKF team was led by Corporate/M&A partner Philippe Weber, Corporate/M&A senior associate Samuel Hochstrasser and Healthcare/Regulatory partner Janine Reudt-Demont, working with associate Pascal Hodel and junior associate Philipp Theiler (both Corporate/M&A) and senior associate Sven Kälin (Tax).

More from Niederer Kraft Frey AG